High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants

Therapeutic Drug Monitoring

Volumn 19, Issue 6, 1997, Pages 694-700

  Salm, Paul ^a   Taylor, Paul J ^a,b   Clark, Andrea ^a   Balderson, Glenda A ^b   Grygotis, Anthony ^c   Norris, Ross L G ^a   Lynch, Stephen V ^b   Shaw, Leslie M ^c   Pond, Susan M ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ELISA; Liver; MEIA I; Renal; Tacrolimus

Indexed keywords

TACROLIMUS;

ACCURACY; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROPARTICLE ENZYME IMMUNOASSAY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MASS SPECTROMETRY; REFERENCE VALUES; TACROLIMUS;

EID: 0031441675     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199712000-00015     Document Type: Article

References (13)

1. Starzl TE, Donner A, Eliasziw M, et al. Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet 1995; 346:1346-50.
2. Jusko WJ, Thomson AW, Fung J, et al. Consensus document: therapeutic monitoring of tacrolimus (FK506). Ther Drug Monit 1995;17:606-14.
3. Takada K, Oh-Hashi M, Yoshikawa H, et al. Determination of a novel potent immunosuppressant chemiluminescence detection. J Chromatogr 1990;530:212-8.
4. Warty V, Zuckerman S, Venkataramanan R, et al. Tacrolimus analysis: a comparison of different methods and matrices. Ther Drug Monit 1995;17:159-67.
5. Firdaous I, Hassoun A, Otte JB, et al. HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients. Clin Chem 1995;41:1292-6.
6. Gonschior A-K, Christians U, Winkler M, et al. Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay. Ther Drug Monit 1995;17:504-10.
7. Taylor PJ, Jones A, Balderson GA, et al. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 1996;42:279-85.
8. Shaw LM, Annesley TM, Kaplan B, et al. Analytic requirements for immunosuppressive drugs in clinical trials. Ther Drug Monit 1995;17:577-83.
9. D'Ambrosio R, Jusko WJ, Stabler T, et al. Improved procedure for enzyme immunoassay of tacrolimus (FK506) in whole blood (letter). Clin Chem 1994;40:159-60.
10. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem 1984;30:290-2.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1: 307-10.
12. Soldin SJ, Morales A. Assessment of current tacrolimus (FK506) assay methods to monitor a pediatric transplant population [abstract]. Clin Chem 1996;42:S213.
13. Ersfeld D, Scheller D, MacFarlane G, et al. Comparison of the IMX assay to the second generation ProTrac II ELISA for the measurement of tacrolimus in whole blood [abstract]. Clin Chem 1996;42:S218.